Cicilia Marques Rodrigues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Cicilia Marques Rodrigues has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alayne Magalhães Trindade Domingues Yamada
Instituto Brasileiro de Controle do Cancer, São Paulo, Brazil
1 shared publication - Auro del Giglio
Centro Universitário FMABC, Santo Andre, SP, Brazil
1 shared publication - Camilla Vieira de Rebouças
Núcleo de Pesquisa e Ensino IBCC Oncologia, São Paulo, SP, Brazil
1 shared publication - Felipe José Silva Melo Cruz
Instituto Brasileiro de Controle do Cancer, São Paulo, Brazil
1 shared publication - Lilian Arruda Do Rêgo Barros
Núcleo de Pesquisa e Ensino do Instituto Brasileiro de Controle do Câncer, São Paulo, SP, Brazil
1 shared publication - Marcos Aurelio Fonseca Magalhaes Filho
Hosp Beneficencia Portuguesa Sao Paulo, Serv Oncol, Sao Paulo, SP, Brazil
1 shared publication
Latest Publications
- Open Access
- 26 October 2021
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 19
High mortality among patients with cancer and COVID-19 infection: the experience of a Brazilian cancer center
Objective To evaluate the severity of COVID-19 in cancer patients to describe clinical and epidemiological factors associated with poor outcomes (mortality and need of intensive care unit admission or mechanical ventilation). Methods Retrospective data from patients with cancer and laboratory diagnosis of COVID-19, obtained between March 16 and May 29, 2020, were retrieved out of a cancer center database. Data analyzed included patient history, age, sex, comorbidities, types of cancer and anticancer therapy. Results This sample comprised 105 patients [...] ABSTRACT Objective To evaluate the severity of COVID-19 in cancer patients to describe clinical and epidemiological factors associated with poor outcomes (mortality and need of intensive care unit admission or mechanical ventilation). Methods Retrospective data from patients with cancer and laboratory diagnosis of COVID-19, obtained between March 16 and May 29, 2020, were retrieved out of a cancer center database. Data analyzed included patient history, age, sex, comorbidities, types of cancer and anticancer therapy. Results This sample comprised 105 patients
- 26 October 2021
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 19
Open AccessHigh mortality among patients with cancer and COVID-19 infection: the experience of a Brazilian cancer center
Objective To evaluate the severity of COVID-19 in cancer patients to describe clinical and epidemiological factors associated with poor outcomes (mortality and need of intensive care unit admission or mechanical ventilation). Methods Retrospective data from patients with cancer and laboratory diagnosis of COVID-19, obtained between March 16 and May 29, 2020, were retrieved out of a cancer center database. Data analyzed included patient history, age, sex, comorbidities, types of cancer and anticancer therapy. Results This sample comprised 105 patients [...] ABSTRACT Objective To evaluate the severity of COVID-19 in cancer patients to describe clinical and epidemiological factors associated with poor outcomes (mortality and need of intensive care unit admission or mechanical ventilation). Methods Retrospective data from patients with cancer and laboratory diagnosis of COVID-19, obtained between March 16 and May 29, 2020, were retrieved out of a cancer center database. Data analyzed included patient history, age, sex, comorbidities, types of cancer and anticancer therapy. Results This sample comprised 105 patients